Cart (0 Items)
Your cart is currently empty.
View Products-
-
-
Tarextumab Biosimilar – Anti-CD52 mAb – Research Grade
| Size | 100ug, 1MG |
|---|---|
| Isotype | IgG2-kappa-lambda |
| Brand | ProteoGenix |
| Product type | Primary Antibodies |
| Clonality | Monoclonal Antibody |
| Expression system | Mammalian cells |
| Applications | Elisa, WB |
| Product name | Tarextumab Biosimilar - Anti-CD52 mAb - Research Grade |
|---|---|
| Source | CAS 1359940-55-8 |
| Species | Caninized |
| Purity | >85% |
| Buffer | PBS buffer PH7.5 |
| Delivery condition | Blue ice (+4°C) |
| Delivery Time | 3-5 days if in stock; 3-5 weeks if production needed |
| Storage condition | store at -80°C |
| Brand | ProteoGenix |
| Aliases /Synonyms | Tarextumab,OMP-59R5,CD52,anti-CD52 |
| Reference | PX-TA1326 |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
| Isotype | IgG2-kappa-lambda |
| Clonality | Monoclonal Antibody |
Description of Tarextumab Biosimilar - Anti-CD52 mAb - Research Grade
General information on Anti-CD52[Homo sapiens] (Tarextumab) Monoclonal Antibody
Tarextumab has beeninvestigated for the treatment of Solid Tumors, Stage IV Pancreatic Cancer, and Stage IV Small Cell Lung Cancer.
Related products
Antigen
CD52 Recombinant Protein
PX-P4084 500$
ELISA
Tarextumab ELISA Kit
KPTX240 1404$Contact us
Send us a message from the form below
Reviews
There are no reviews yet.